Cargando…

Anticoagulation management : a guidebook for pharmacists /

In addition to acting as a training guide for pharmacists, pharmacy residents and pharmacy students who seek to practice in areas associated with patients on anticoagulant therapy, the information presented within highlights the growing role of the pharmacist in these contexts. Readers will find use...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Rose, Anne (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Adis, 2015.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn922925389
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 151006s2015 sz ob 000 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d IDEBK  |d YDXCP  |d OCLCF  |d CDX  |d EBLCP  |d AZU  |d COO  |d GW5XE  |d VT2  |d Z5A  |d OCLCQ  |d ESU  |d IOG  |d U3W  |d MERUC  |d CEF  |d INT  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d UKMGB  |d OCLCQ  |d UKAHL  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCA  |d AJS  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ 
016 7 |a 019128816  |2 Uk 
019 |a 931592203  |a 932333131  |a 985045869  |a 1005753366  |a 1011847766 
020 |a 9783319226026  |q (electronic bk.) 
020 |a 3319226029  |q (electronic bk.) 
020 |z 9783319226019 
020 |z 3319226010  |q (print) 
020 |z 9783319226019  |q (print) 
024 7 |a 10.1007/978-3-319-22602-6  |2 doi 
029 1 |a AU@  |b 000058376549 
029 1 |a AU@  |b 000060385579 
029 1 |a NZ1  |b 16246390 
029 1 |a UKMGB  |b 019128816 
035 |a (OCoLC)922925389  |z (OCoLC)931592203  |z (OCoLC)932333131  |z (OCoLC)985045869  |z (OCoLC)1005753366  |z (OCoLC)1011847766 
037 |a com.springer.onix.9783319226026  |b Springer Nature 
050 4 |a RM340 
060 4 |a QV 193 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MBGR  |2 bicssc 
082 0 4 |a 615.718  |2 23 
049 |a UAMI 
245 0 0 |a Anticoagulation management :  |b a guidebook for pharmacists /  |c Anne Rose, editor. 
264 1 |a Cham :  |b Adis,  |c 2015. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
588 0 |a Online resource; title from PDF title page (EBSCO, viewed October 7, 2015). 
504 |a Includes bibliographical references. 
505 0 |a Anticoagulation Management; Preface; Abbreviations; Contents; Contributors; Part 1: Medication Management; Chapter 1: Inpatient Warfarin Management; 1.1 Introduction; 1.2 Case Examples; 1.2.1 Case 1; 1.2.2 Case 2; 1.2.3 Case 3; 1.3 Role of the Pharmacist in Inpatient Vitamin K Antagonist Management; 1.4 Warfarin Management Guidelines and Protocols; 1.4.1 Warfarin Initiation; 1.4.2 Warfarin Maintenance; 1.5 Monitoring and Interpreting Laboratory Values; 1.5.1 International Normalized Ratio (INR); 1.5.2 Complete Blood Count (CBC); 1.5.3 Pregnancy Testing; 1.5.4 Genetic Testing. 
505 8 |a 1.6 Assessment of Drug Interactions1.7 Patient Education; 1.8 Documentation; 1.9 Conclusions; References; Chapter 2: Ambulatory Warfarin Management; 2.1 Introduction; 2.2 Case Examples; 2.2.1 Case 1; 2.2.2 Case 2; 2.2.3 Case 3; 2.3 Role of the Pharmacist in Ambulatory Warfarin Management; 2.4 Warfarin Management Guidelines and Protocols; 2.4.1 Indication for Warfarin Therapy; 2.4.2 Patient Assessment; 2.4.3 Initial Warfarin Dosing; 2.4.4 Maintenance Warfarin Dosing; 2.5 Monitoring Laboratory Values and Patient Assessment; 2.5.1 Monitoring Laboratory Values; 2.5.2 Patient Assessment. 
505 8 |a 2.6 Assessment of Drug Interactions2.7 Patient Education and Compliance; 2.7.1 Patient Education; 2.7.2 Patient Compliance; 2.8 Documentation; 2.9 Conclusion; References; Chapter 3: Unfractionated Heparin and Low Molecular Weight Heparin; 3.1 Introduction; 3.2 Case Examples; 3.2.1 Case 1; 3.2.2 Case 2; 3.2.3 Case 3; 3.3 The Role of the Pharmacist; 3.3.1 UFH Management; 3.3.2 LMWH Management; 3.4 Management Guidelines and Protocols; 3.4.1 UFH Management Guidelines and Protocols; 3.4.2 LMWH Management; 3.5 Monitoring and Interpreting Laboratory Values; 3.5.1 Maintenance Monitoring of UFH. 
505 8 |a 3.5.2 Maintenance Monitoring of LMWH3.6 Documentation; 3.7 Patient Education; 3.8 Future Roles; 3.9 Conclusion; References; Chapter 4: Direct Oral Anticoagulants; 4.1 Introduction; 4.2 Case Examples; 4.2.1 Case 1; 4.2.2 Case 2; 4.3 Pharmacist Role in DOAC Management; 4.4 DOAC Drug Selection and Management; 4.4.1 Anticoagulant Selection [5-17]; Prosthetic Heart Valves; Geriatric Patients; Renal Impairment; Dialysis; Hepatic Impairment; Pregnancy/Lactation; Pediatrics; Contraindications; 4.4.2 DOAC Selection; 4.4.3 DOAC Dosing; 4.5 Monitoring and Interpreting Laboratory Values. 
505 8 |a 4.5.1 Labs to Determine Coagulation Status [20, 21]4.5.2 Labs to Monitor for Appropriate DOAC Dosing [8-17, 19]; 4.6 Drug Interactions [22]; 4.6.1 Pharmacokinetic Drug Interactions; P-gp Inhibitors and Inducers; CYP 3A4 Inhibitors and Inducers; 4.6.2 Pharmacodynamic Drug Interactions; Medications that Inhibit Platelet (PLT) Aggregation; 4.7 Transitioning Between Anticoagulants [23-25, 27]; 4.7.1 Periprocedural Planning; 4.7.2 Reversal Strategies [28]; 4.8 Patient Education [19]; 4.9 Future Roles; 4.9.1 Anticoagulation Clinics; 4.9.2 Reimbursement; 4.10 Conclusion; References. 
520 |a In addition to acting as a training guide for pharmacists, pharmacy residents and pharmacy students who seek to practice in areas associated with patients on anticoagulant therapy, the information presented within highlights the growing role of the pharmacist in these contexts. Readers will find useful information on anticoagulant management across all pharmacy practice areas, including the inpatient, ambulatory, emergency services and transitions of care settings. Particular attention is given to summarizing best practices and providing 'real world' examples of ways in which pharmacists can be involved in anticoagulation management and the impact of such involvement. In the first major section of the book, each chapter focuses on the role of the pharmacist in the management of medication with a specific type of anticoagulants (e.g. warfarin, heparin and target-specific oral agents) in various healthcare settings. A broader overview of the clinical management of anticoagulation therapy is provided in the second major section, including descriptions of the role of pharmacists in assessing venous thromboembolism risk, ensuring patients receive appropriate prophylactic therapy, and monitoring outcomes. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Anticoagulants (Medicine) 
650 2 |a Anticoagulants  |x therapeutic use 
650 2 |a Anticoagulants 
650 6 |a Anticoagulants. 
650 7 |a Pharmacology.  |2 bicssc 
650 7 |a Medical research.  |2 bicssc 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Anticoagulants (Medicine)  |2 fast 
700 1 |a Rose, Anne,  |e editor. 
776 0 8 |i Print version:  |a Rose, Anne.  |t Anticoagulation Management : A Guidebook for Pharmacists.  |d Cham : Springer International Publishing, ©2015  |z 9783319226019 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4178498  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH31356678 
938 |a Coutts Information Services  |b COUT  |n 32812798 
938 |a EBL - Ebook Library  |b EBLB  |n EBL4178498 
938 |a EBSCOhost  |b EBSC  |n 1076497 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis32812798 
938 |a YBP Library Services  |b YANK  |n 12635240 
994 |a 92  |b IZTAP